{
  "source_attachment": {
    "filename": "image(20261027-190911).png",
    "path": ""
  },
  "document": {
    "title_or_product": "Novarex (velantrazine) 20 mg tablets — two contrasting prescription-drug advertisements",
    "summary": "A side-by-side comparison of two advertisements for the same fictional prescription medicine, presented as a treatment for moderate to severe rheumatoid arthritis. The left advertisement uses restrained claims and prominent safety information. The right uses stronger emotional appeals, an unsubstantiated numerical claim, and a much less prominent safety disclosure. The product and its clinical claims are fictional, so their scientific and evidential validity cannot be established from the image."
  },
  "marks": [
    {
      "id": "m01",
      "description": "The left advertisement claims that Novarex has been proven in clinical trials without identifying the trials or providing verifiable supporting information.",
      "locations": [
        {
          "text": "Proven in clinical trials",
          "bbox": [0.094, 0.578, 0.183, 0.638]
        },
        {
          "text": "Help reduce joint pain and stiffness.",
          "bbox": [0.031, 0.269, 0.269, 0.452]
        }
      ],
      "assessments": [
        {
          "field": "TATD",
          "score": 0.45,
          "reason": "The advertisement makes a product-specific claim of clinical proof but gives no identifiable trial, comparator, sample size or results. The claimed benefit is comparatively restrained, however, and the absence of a citation in the advertisement does not demonstrate that supporting trials do not exist."
        }
      ],
      "recommendation": "Verify that suitable clinical evidence supports the advertised reduction in pain and stiffness. Identify the supporting study or provide an accessible reference, and ensure that the benefit claim accurately reflects its findings.",
      "revised_text": ""
    },
    {
      "id": "m02",
      "description": "The right advertisement presents an apparently impressive clinical result without sufficient information to interpret or verify it.",
      "locations": [
        {
          "text": "82% FELT BETTER IN JUST 4 WEEKS!",
          "bbox": [0.524, 0.378, 0.666, 0.62]
        },
        {
          "text": "Results reported by the manufacturer. Further details available on request.",
          "bbox": [0.528, 0.939, 0.934, 0.97]
        }
      ],
      "assessments": [
        {
          "field": "TATD",
          "score": 0.95,
          "reason": "The headline supplies a precise percentage and treatment period but no identifiable study, number of participants, comparator, definition of feeling better, magnitude of improvement or statistical uncertainty. The small qualification at the bottom does not make the claim independently verifiable."
        },
        {
          "field": "RM",
          "score": 0.35,
          "reason": "The precise, conspicuous benefit figure is supported only by a much less prominent qualification at the bottom. This creates an imbalance in the presentation, although the qualification concerns evidence rather than a specific medical hazard."
        }
      ],
      "recommendation": "Provide an identifiable study and enough information to interpret the percentage, including the endpoint, sample size, comparator and actual results. Remove or qualify the numerical headline unless the evidence supports the precise advertised claim.",
      "revised_text": ""
    },
    {
      "id": "m03",
      "description": "The right advertisement uses emphatic promises and celebratory imagery to suggest a broad restoration of health, mobility and personal freedom beyond the clinical benefit established in the advertisement.",
      "locations": [
        {
          "text": "Get your life back!",
          "bbox": [0.539, 0.169, 0.951, 0.362]
        },
        {
          "text": "Be more active Enjoy life again",
          "bbox": [0.737, 0.561, 0.869, 0.647]
        },
        {
          "text": "A breakthrough new treatment",
          "bbox": [0.738, 0.64, 0.877, 0.713]
        },
        {
          "text": "",
          "bbox": [0.736, 0.298, 0.982, 0.783]
        },
        {
          "text": "Novarex is a breakthrough treatment that works directly on the body's inflammatory pathways, restoring mobility and freedom.",
          "bbox": [0.552, 0.801, 0.962, 0.853]
        }
      ],
      "assessments": [
        {
          "field": "VP",
          "score": 0.98,
          "reason": "The triumphant expressions, raised arms, outdoor scenery and large emotional headline create an exceptionally strong impression of restored vitality, happiness and freedom."
        },
        {
          "field": "TATD",
          "score": 0.88,
          "reason": "The advertisement provides no checkable evidence establishing that treatment restores mobility and freedom to the broad degree implied by the promises and imagery. The wording also goes beyond the more limited proposition that a medicine may reduce arthritis symptoms."
        },
        {
          "field": "SD",
          "score": 0.35,
          "reason": "The broad assertion that treatment restores mobility and freedom may extend a narrower therapeutic effect into a stronger general conclusion. Nevertheless, acting on inflammatory pathways is not inherently implausible, and the advertisement alone does not establish that the proposed mechanism is scientifically false."
        }
      ],
      "recommendation": "Replace the sweeping restoration promises with a specific, clinically supportable account of the benefit. Reconsider the combination of imagery and wording so it does not imply near-complete recovery or a transformation of everyday life unsupported by evidence. Positive imagery need not be removed if the resulting impression is justified.",
      "revised_text": ""
    },
    {
      "id": "m04",
      "description": "The right advertisement gives its benefits far greater visual emphasis than its potentially serious adverse effects, which are relegated to comparatively small text at the bottom.",
      "locations": [
        {
          "text": "Novarex may cause nausea, dizziness and headache. More serious side effects, including severe infections and liver problems, have been reported.",
          "bbox": [0.526, 0.873, 0.965, 0.926]
        },
        {
          "text": "Get your life back!",
          "bbox": [0.539, 0.169, 0.951, 0.362]
        },
        {
          "text": "ASK YOUR DOCTOR TODAY!",
          "bbox": [0.59, 0.724, 0.908, 0.784]
        }
      ],
      "assessments": [
        {
          "field": "RM",
          "score": 0.92,
          "reason": "The benefit promises and call to action dominate the advertisement through very large lettering, strong colours and central placement. The warning concerning severe infections and liver problems is substantially less prominent and separated from those promises. The warning is readable, but the overall presentation strongly favours benefits."
        },
        {
          "field": "SC",
          "score": 0.7,
          "reason": "The advertisement itself identifies serious potential adverse effects, including infections and liver problems. These warrant careful review of the risk information and its adequacy. Because Novarex is fictional, their actual incidence, severity, contraindications and clinical significance cannot be independently established."
        }
      ],
      "recommendation": "Give the safety information substantially greater prominence and ensure that the overall presentation balances benefits and material risks. For a real product, verify all warnings against authoritative product information and have the complete advertisement reviewed against the applicable jurisdictional requirements.",
      "revised_text": ""
    }
  ]
}